Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

TUESDAY, Nov. 28, 2023 -- Personal trainers can help people increase their strength and their fitness.

Could a “brain coach” be just as useful in preventing Alzheimer’s’ disease?

A new study suggests that personalized health and lifestyle changes can delay or even prevent memory loss for older adults at high risk of Alzheimer’s or dementia.

People who received personal coaching experienced a 74% boost in their thinking and memory tests compared with those who didn’t receive such attention.

“This is the first personalized intervention, focusing on multiple areas of cognition, in which risk factor targets are based on a participant’s risk profile, preferences and priorities, which we think may be more effective than a one-size-fits-all approach,” said co-lead researcher Dr. Kristine Yaffe, vice chair of research in psychiatry at the University of California, San Francisco (UCSF).

For the study, researchers recruited 172 participants and assigned half to receive personal training in health and lifestyle areas believed to increase Alzheimer’s risk.

The participants were between the ages of 70 and 89, and all had at least two of eight risk factors for dementia -- physical inactivity, high blood pressure, uncontrolled diabetes, poor sleep, use of prescription medications associated with risk of cognitive decline, high depressive symptoms, social isolation and smoking.

Patients met with a nurse and health coach and selected specific risk factors they wanted to address. They set personal goals like upping their number of daily steps or tracking their high blood pressure, and received coaching sessions every few months to review their progress.

Along with the boost in cognitive scores, participants also experienced a 145% improvement in their risk factors compared to those who didn’t get coaching, as well as an 8% improvement in their quality of life.

The meetings started in person and switched to phone calls during the pandemic, but that didn’t seem to affect the effectiveness of the coaching.

“We were pleasantly surprised that the positive results of the trial were not offset by the impact of the pandemic,” said co-lead researcher Dr. Eric Larson, a professor of medicine at University of Washington.

“We know that isolation from social distancing took a heavy toll on cognition, social lives, and mental and physical health in some older adults,” Larson added. “But participants in the intervention group fared better cognitively and had fewer risk factors after the trial, during the pandemic, than they did before.”

Such risk-reduction programs are a lot less expensive than pricey new Alzheimer’s drugs like Aduhelm and Leqembi, Yaffe said. They also don’t have strict eligibility criteria, and don’t require extensive monitoring for potential side effects like brain bleeding.

“Hopefully in the future, treatment of Alzheimer’s and related dementias will be like cardiovascular disease management, with a combination of risk-reduction and specific drugs targeted for disease mechanisms,” Yaffe said in a UCSF news release.

The study was published Nov. 27 in the journal JAMA Internal Medicine.

Sources

  • University of California, San Francisco, news release, Nov. 27, 2023

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-11-28 20:32

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords